Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Suppressing certain hormones might help prevent prostate cancer.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

Chicken egg yolk peptides can promote hair growth by increasing a specific growth factor.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Liposomes and niosomes improve finasteride delivery for hair loss treatment.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Ketoconazole shampoo with finasteride improves hair density in men with hair loss.

Improved hair loss treatment using special particles and surfactants.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Urtica dioica extract may help treat androgenic skin diseases by reducing a specific gene's activity.

Male pattern baldness does not cause an increased risk of prostate cancer.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Dihydrotestosterone (DHT) and its active metabolites play a key role in various diseases, and the development of 5α-reductase inhibitors can help treat these conditions.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.